Cemiplimab as Second-Line Therapy for Patients with Recurrent Cervical Cancer: A United States-based Cost-effectiveness Analysis
Kun Liu, Youwen Zhu, Yangying Zhou, Hong Zhu
Topics & Concepts
MedicineCervical cancerInternal medicineRheumatologyOncologyPhysical therapyFamily medicineCancerEndometrial and Cervical Cancer TreatmentsHealth Systems, Economic Evaluations, Quality of LifeEconomic and Financial Impacts of Cancer